Ruijuan Zhou acquired 28.00 million shares of TOUYUN BIOTECH via an off-exchange equity derivative transaction on September 24, 2026.
Prior to the acquisition, Ruijuan Zhou's long position in TOUYUN BIOTECH was 0 shares, representing 0.00%; following the acquisition, the holding changed to 28.00 million shares, with the long position ratio rising to 0.96%.